Jynneos Market Report 2026

Jynneos Market Overview

• The Jynneos market growth in the historic period has been driven by global smallpox eradication efforts, past monkeypox outbreaks • Market expansion is supported by increasing zoonotic disease risks, expansion of national vaccine reserves • Growth Driver: Rising Monkeypox Cases Fuel Growth In The Jynneos Vaccine Market • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Jynneos Market?

Jynneos is a vaccine designed to protect both monkeypox and smallpox. It includes a modified, non-replicating vaccinia virus, which is similar to the virus used in traditional smallpox vaccines but does not replicate in the body. The immune response enables the body to recognize and fight off monkeypox and smallpox viruses if exposed in the future, providing long-lasting protection. The main types of indications for jynneos are prevention of monkeypox and prevention of smallpox. Monkeypox prevention involves using Jynneos vaccine to protect high-risk individuals from the virus transmitted through close contact or animals. It is available in various formulations, such as injectable formulation, lyophilized powder for reconstitution. It is distributed through various channels such as direct sales, wholesalers and distributors, retail pharmacies, online pharmacies, and is used by various end users including hospitals, specialty clinics, public health organizations, home healthcare providers.

What Is The Jynneos Market Growth Forecast?

The growth in the forecast period can be attributed to increasing zoonotic disease risks, expansion of national vaccine reserves, rising funding for biodefense, improved global surveillance systems, broader adult immunization programs. Major trends in the forecast period include rising focus on emerging infectious disease prevention, expansion of non replicating vaccine technologies, growth in government immunization programs, increased stockpiling of strategic vaccines, rising awareness of zoonotic diseases.

Global Jynneos Market Segmentation

1) By Indication: Prevention of Monkeypox, Prevention of Smallpox 2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution 3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations 4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies 5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers

What Are The Drivers Of The Jynneos Market?

The rising prevalence of monkeypox cases is expected to boost the jynneos market going forward. Monkeypox is a viral disease caused by the monkeypox virus, which belongs to the orthopoxvirus family. Monkeypox cases arise due to increased global travel and the more significant interaction between wildlife and humans that facilitate the rapid movement of infectious agents, turning isolated outbreaks. Jynneos is beneficial for monkeypox cases as it effectively prevents the virus in at-risk individuals and is safer for people with weakened immune systems compared to traditional smallpox vaccines. For instance, in September 2024, according to the European Centre for Disease Prevention and Control, a Europe-based government agency, from January 2022 to July 2024, over 100,000 confirmed cases of pox due to monkeypox virus (MPXV) clade I and clade II, including over 200 deaths, were reported by more than 120 countries globally. Therefore, increasing monkeypox cases are driving the growth of the Jynneos industry. The key company operating in the jynneos market focuses on developing combined vaccines to address multiple disease targets simultaneously. Combined vaccines refer to immunizations that protect against multiple diseases in a single shot, reducing the number of injections needed for full immunization. For instance, in August 2024, Bavarian Nordic A/S, a Denmark-based biotechnology company, announced that Singapore’s Health Sciences Authority (HSA) had approved JYNNEOS (MVA-BN) to prevent smallpox and pox in adults aged 18 and older who are considered at high risk for these infections. JYNNEOS (MVA-BN) is a non-replicating vaccine designed to offer a safer alternative for individuals, including immunocompromised individuals. It was developed to enhance public health preparedness and address emerging infectious diseases.

Key Players In The Global Jynneos Market

Major companies operating in the jynneos market are Bavarian Nordic A/S

What Are Latest Mergers And Acquisitions In The Jynneos Market?

In May 2024, Bavarian Nordic A/S, a Denmark-based manufacturer of Jynneos, partnered with the Coalition for Epidemic Preparedness Innovations (CEPI). The partnership aims to advance the development of Bavarian Nordic’s mpox vaccine for children in Africa, ensuring its safety and efficacy in endemic regions. This collaboration also seeks to support regulatory approval for the vaccine’s use in children. Coalition for Epidemic Preparedness Innovations (CEPI) is a Norway-based non-profit organization focused on accelerating the development of vaccines and biologic countermeasures against epidemic and pandemic threats.

Regional Insights

North America was the largest region in the jynneos market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Jynneos Market?

The jynneos market consists of sales of jynneos vaccine vials (multi-dose) and jynneos vaccine pre-filled auto-injectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Jynneos Market Report 2026?

The jynneos market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the jynneos industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.